Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.
The study will investigate whether women with clear-cell cancer may benefit from treatment with a new anti-cancer drug called pembrolizumab. All women in the study will receive the study drug, pembrolizumab, for up to two years or: until their study doctor thinks the study drug is no longer helping to control the cancer if unacceptable sid…
Researchers are conducting the PROMPT trial to see if the study drug (pembrolizumab) can be used as a maintenance treatment to slow the growth/return of cancer after treatment with paclitaxel (standard chemotherapy drug). Normally, after receiving paclitaxel, patients are observed without treatment as maintenance treatment is not standard for this …
For a woman who is at increased of developing ovarian cancer, the standard practice is to offer an operation to remove both tubes and ovaries. This is undertaken after a woman has completed her family. It's called 'risk reducing salpingo oophorectomy' or RRSO. (Salpingo-oophorectomy means removing tubes and ovaries.) Removing both tubes and ovar…
Gynaecological cancer patients are all managed within 34 Cancer Centres located across the UK. These centres are only likely to see 1–5 new patients per year with rare gynaecological cancers. The low numbers of these cancers means that no single doctor or centre in the UK (or internationally) can hope to gain sufficient experience to be able to con…
The aims of the trial are to: help diagnose ovarian cancer earlier when treatment is likely to work better help identify which women need further investigations for possible ovarian cancer and reduce unnecessary tests, hospital visits and distress in women who do not have ovarian cancer try to develop a blood test that is more specific an…
Genetic testing in ovarian cancer patients is now being implemented across the NHS and offers genetic testing to patients diagnosed with certain types of cancer affecting the ovary, fallopian tube or peritoneum. It's hoped that by doing this, patients across the NHS will have even better treatments and that in some families, cancers will be prevent…
Sign up to receive emails from Target Ovarian Cancer, including our monthly newsletter, and be the first to hear about campaigns, upcoming events and fundraising inspiration.
Sign up
